Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating AC chemotherapy followed by weekly docetaxel as neoadjuvant treatment for breast cancer; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
A completed clinical trial evaluated cardiac function using cardiac MRI and analyzed its relationship with dosimetric radiation parameters i…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin [Phase 2]
A Phase 2 trial evaluated detection and prevention of anthracycline-related cardiac toxicity with concurrent simvastatin in breast cancer pa…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy [Phase 3]
Phase 3 trial suggesting zinc-L-carnosine may prevent dysphagia in breast cancer patients undergoing adjuvant radiotherapy.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial comparing pyrotinib plus vinorelbine against physician's choice in HER2-positive metastatic breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of SHR6390 (CDK4/6 inhibitor) with Pyrotinib for HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients [Phase 3]
A Phase 3 trial comparing neoadjuvant hormonal therapy to neoadjuvant chemotherapy in stage IIIB/C and IV breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating apatinib in combination with oral vinorelbine for metastatic HER2-negative breast cancer is ongoing with…
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC [NA]
Clinical trial update reporting spect analysis of cardiac perfusion changes after whole-breast/chest-wall radiation therapy using ABC.
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer [Phase 3]
Phase 3 trial evaluating intrathecal liposomal cytarabine (DepoCyte) for leptomeningeal metastases from breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration [Phase 3]
A Phase 3 clinical trial evaluated tolerability of subcutaneous trastuzumab administration in HER2-positive early breast cancer using a sing…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update investigating carboplatin and eribulin mesylate in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca [Phase 2]
Phase II trial of Allo LMI vaccine with IL-2 for stable metastatic breast cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment [Phase 3]
A Phase 3 trial evaluating testosterone to treat arthralgia in postmenopausal breast cancer patients experiencing joint pain from aromatase …
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive [Phase 1, Phase 2]
Clinical trial update for a T cell receptor therapy targeting MAGE-A3 in HLA-A*01 positive patients with metastatic cancer; the study is ter…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Oxybutynin Chloride in Managing Hot Flashes [Phase 3]
Phase 3 trial investigating oxybutynin chloride for managing hot flashes in breast cancer patients; study completed with posted results in 2…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers [NA]
Clinical trial update for the Nueva Vida intervention addressing quality of life in Latina breast cancer survivors and caregivers; study com…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer [Phase 1]
Phase 1 trial evaluating tamoxifen in combination with ribociclib (LEE011) for advanced ER+ (HER2-negative) breast cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Vaccination of High Risk Breast Cancer Patients [Phase 1]
Phase 1 clinical trial update on vaccination in high-risk breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-05-30Clinical Trial Update: Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation [Phase 3]
Phase 3 clinical trial update evaluating 16α-[18F]Fluoro-17β-estradiol PET imaging correlation with ESR1 mutation in breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy [Phase 2]
Phase 2 trial update on glutamine for prevention of radiation toxicity in breast cancer patients undergoing therapy; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: TRial on the Endocrine Activity of Neoadjuvant Degarelix [Phase 2]
Phase 2 trial evaluating the endocrine activity of neoadjuvant degarelix in invasive breast cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib plus vinorelbine in HER2-positive metastatic breast cancer patients with brain metastases.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating intrathecal trastuzumab for leptomeningeal metastases in HER2-positive breast cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab in recurrent stage IV HER2-negative inflammatory breast cancer; study terminated with resu…